Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China

• Autores principales: Guoqing Liu (Autor), Kun Huang (Autor), Gang Li (Autor), Yingzi Zhen (Autor), Zhengping Li (Autor), Zhenping Chen (Autor), Runhui Wu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

BackgroundAs a new non-factor therapy for hemophilia A (HA), real-world study of emicizumab is still scarce. This study aimed to investigate the real-world use of emicizumab in Chinese boys with HA.MethodsPatients with moderate or severe HA were enrolled at Beijing Children's Hospital. They tak...